Based on our observations of more than 250 European and U.S. financial institutions, this report helps you fine tune your marketing strategy (segmentation, target, marketing mix, etc.) to reach consumers under 30 years of age.

Our report answers three main questions:

• What options are available as far as the segmentation of the junior population is concerned?
• Is there a specific marketing objective for each age segment with regard to customer acquisition, customer loyalty, and business volume?
• For each age segment, how do European financial institutions configure their marketing mix to achieve this objective?

• Follow movement in each drug price, by therapeutic area and by country
• Track the market access conditions for each drug
• Monitor the approval of new competitor products
• One-click comparisons of individual-drug prices across the EU top-5 and the United States
• Instantly compare daily treatment costs of specific drugs
• Instantly compare ex-factory prices of each active ingredient throughout a drug or therapeutic class
• Compare the price & reimbursement status of drugs or therapeutic class
• Analyze time to market access according to authorization process or therapeutic area